← back to search

Eric H. Y. Lau

International University of Batam · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include COVID-19 epidemiological studies, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, and Respiratory viral infections research.
h-index
64
citations
37,995
works
415
NIH funding
primary concept
Medicine
email

Recent publications

The Prevalence of Anabolic-Androgenic Steroid Use Among Same-Sex Attracted Men: A Systematic Literature Review and Meta-Analysis.
2026cited by 1position: contributordoi
A retrospective study on laboratory‐confirmed acute Chinese medicine poisoning involving aconite in Hong Kong from 2008 to 2020
Hong Kong Journal of Emergency Medicine 2026cited by 0position: contributordoi
Postnatal care utilisation among women with disabilities: through the lens of intersectionality of disability and socioeconomic status
Midwifery 2026cited by 0position: contributordoi
Effective Real-time Transmission Estimations Incorporating Population Viral Load Distributions Amid SARS-CoV-2 Variants and Preexisting Immunity.
2025cited by 3position: contributordoi
Impact of Population Immunity and Public Health Measures on the Transmission of Omicron Subvariants BA.2 and BA.5 in Hong Kong.
2025cited by 1position: contributordoi
Retrospective assessment of vaccination policy optimizations during an Omicron BA.2 epidemic in Hong Kong: A modelling study.
2025cited by 1position: contributordoi
Diagnostic serial interval as an alternative measure of clinical serial interval using ancestral COVID-19 waves in Hong Kong and mainland China
2025cited by 0position: contributordoi
Association between out-of-pocket health expenditures and low birth weight in Eastern Ethiopia: a generalized structural equation modeling (GSEM).
2025cited by 0position: contributordoi
Derivation and internal validation of a clinical diagnostic score for acute Chinese medicine poisoning involving aconite.
2025cited by 0position: contributordoi
Collective interactions, human mobility and viral evolution shaped the SARS-CoV-2 transmission in Mainland China
2025cited by 0position: contributordoi
Ensemble forecasting of influenza activity and assessing its year-round dynamical characteristics during and post-COVID-19 pandemic periods in a sub-tropical location
2025cited by 0position: contributordoi
Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study
The Lancet Regional Health - Western Pacific 2024cited by 29position: contributordoi
Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
2024cited by 18position: contributordoi
Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation.
2024cited by 15position: contributordoi
Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12–17 years following SARS-CoV-2 Omicron infection: A target trial emulation
Nature Communications 2024cited by 10position: middledoi
Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong.
2024cited by 10position: contributordoi
Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12-17 years following SARS-CoV-2 Omicron infection: A target trial emulation.
2024cited by 8position: contributordoi
Assessing the Impact of Primary-Series Infection and Booster Vaccination on Protection against Omicron in Hong Kong: A Population-Based Observational Study.
2024cited by 5position: contributordoi
Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach.
2024cited by 4position: contributordoi
Estimation of the Time-Varying Effective Reproductive Number of COVID-19 Based on Multivariate Time Series of Severe Health Outcomes.
2024cited by 4position: contributordoi
Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population.
2024cited by 4position: contributordoi
Predicting Efficacies of Fractional Doses of Vaccines by Using Neutralizing Antibody Levels: Systematic Review and Meta-Analysis.
2024cited by 3position: contributordoi
Early sepsis care with the National Early Warning Score 2-guided Sepsis Hour-1 Bundle in the emergency department: hybrid type 1 effectiveness-implementation pilot stepped wedge randomised controlled trial (NEWS-1 TRIPS) protocol.
2024cited by 3position: contributordoi
Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong
Vaccine 2024cited by 2position: contributordoi
Decreased risk of non-influenza respiratory infection after influenza B virus infection in children.
2024cited by 2position: contributordoi
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection
International Journal of Antimicrobial Agents 2024cited by 1position: middledoi
Comparative Effectiveness of Antivirals and Monoclonal Antibodies for Treating COVID‐19 Patients Infected With Omicron Variant: A Systematic Review and Network Meta‐Analysis
Influenza and Other Respiratory Viruses 2024cited by 1position: middledoi
Hospital costs of COVID-19, post-COVID-19 condition and other viral pneumonias: a cost comparison analysis.
2024cited by 1position: contributordoi
Comparative Effectiveness of Antivirals and Monoclonal Antibodies for Treating COVID-19 Patients Infected With Omicron Variant: A Systematic Review and Network Meta-Analysis.
2024cited by 1position: contributordoi
Immuno-persistence after the 4th and 5th dose of inactivated polio vaccines in school-aged children
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 91 papers (2020–2026)Benjamin J. Cowling · Laboratory of Data Discovery for Health59 papers (2016–2025)Peng Wu · Institute of Zoology50 papers (2017–2025) · 44 papers (2020–2025)GM Leung · University of Utah23 papers (2016–2024) · 22 papers (2020–2025)Lin Wang · Inner Mongolia Agricultural University15 papers (2020–2025) · 15 papers (2020–2024)Carlos K. H. Wong · University of London15 papers (2022–2024)Jessica Y. Wong · University of Pennsylvania15 papers (2017–2025)Malik Peiris · Prince of Wales Hospital14 papers (2015–2024) · 12 papers (2020–2025) · 11 papers (2021–2024)David S.C. Hui · The University of Texas MD Anderson Cancer Center9 papers (2021–2024) · 9 papers (2021–2024)Kathy Leung · London School of Hygiene & Tropical Medicine9 papers (2019–2024)Hongjie Yu · Fudan University9 papers (2015–2020)Zhanwei Du · Hong Kong Science and Technology Parks Corporation8 papers (2020–2024)Sheikh Taslim Ali · Hong Kong Science and Technology Parks Corporation8 papers (2020–2025)Juan Yang · Yunnan University7 papers (2015–2020)